A startup that wants to build a blood test to screen for cancer just merged with a Hong Kong-based company that's also looking at early cancer detection.
ADVERTISEMENT
A startup backed by Bill Gates that's building an early cancer detection test just pulled off a big deal
A startup that wants to build a blood test to screen for cancer just merged with a Hong Kong-based company that's also looking at early cancer detection.
Grail CEO Jeff Huber
ADVERTISEMENT
Recommended articles
Grail and Cirina are combining, the companies announced Wednesday. Terms of the merger weren't given.
Cirina was cofounded by Dennis Lo, a professor of chemical pathology, who is known for his work on noninvasive prenatal testing. The test uses a sample of blood to screen for cell-free DNA that can check for chromosomal problems including Down syndrome.
The hope is to possibly translate that work into other disease areas, including early cancer detection. Lo is joining Grail's scientific advisory board as part of the merger. The move also will help Grail one day commercialize in Asia.
ADVERTISEMENT
Since it got its start in 2016, Grail has raised more than $1 billion, from the likes of Jeff Bezos and Bill Gates, along with big names from the pharmaceutical, tech, and healthcare industries, including Johnson & Johnson Innovation, ARCH Venture Partners, Amazon, Bristol-Myers Squibb, Celgene, and Merck.
The idea behind a cancer-screening test is to identify the tiny bits of cancer DNA that are hanging out in our blood but are now undetectable. If companies like Grail are successful, they would be the first to pull off a cancer-detecting blood test that works proactively. The concept is similar to liquid biopsy tests, which use blood samples to sequence genetic information in that blood to figure out how tumors are responding to a certain cancer therapy.
With one sample of blood (the same you might have drawn at the doctor's to check your cholesterol or blood-sugar levels), Grail's plan is to sequence and screen for those bits with the hope that it will help catch cancer before it starts to be a full-blown problem.
Getting to that point won't be easy, and Grail has started recruiting for large clincal trials, including one that plans to enroll 120,000 women.
FOLLOW BUSINESS INSIDER AFRICA
ADVERTISEMENT
Recommended articles
Changes in the net worth of Africa's 10 richest men since January
France to back Morocco's power link to Western Sahara
Kenya’s Ruto backs Zimbabwe’s ZiG currency for economic prosperity
Here’s another reason Nigeria is losing billions of dollars annually
Top 10 African countries with the lowest fuel prices in April 2024
How SafeHamsters unlocks the potential of crypto betting| Insider Tips
A look into the diverse tax reforms being implemented across Africa
Dubai firm to lend South Sudan $12.9 billion in exchange for 20 years oil repayment
